An Expression Signature Model To Predict Lung Adenocarcinoma-Specific Survival
from Cancer Management and Research
The current TNM staging system plays a central role in lung adenocarcinoma (LUAD) prognosis. However, it may not adequately stratify the risk of tumor recurrence. With the aid of gene expression profiling, we identified 31 lncRNAs whose expressions in tumor tissues could be used as a risk indicator for the guidance of lung cancer therapy. This exploratory analysis may shed new light on identification of potential prognostic factors.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063